As biologics and novel modalities become increasingly sophisticated, understanding molecular structure under controlled conditions tells only part ...
For emerging biopharma companies, speed, quality and scalability cannot be treated as separate priorities. As products progress t...
Scientific breakthroughs are advancing rapidly across complex biologics, cell and gene therapies, radiopharmaceuticals and ADCs, but translating th...
As cell and gene therapies progress towards broader commercialisation, scientific innovation alone is no longer enough. The next generation of ther...
As advanced therapies move from development towards commercial scale, quality is becoming far more than a regulatory checkpoint. It is increasingly...
Early detection remains one of the biggest challenges in cancer care, particularly for ovarian cancer, where symptoms can be difficult to r...
At INTERPHEX, sustainability and supply chain performance emerged as important priorities for pharmaceutical packaging. John Jansen, Head of Global Marketi...
As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors im...
Drug development is inherently uncertain, with scientific discoveries, manufacturing challenges, regulatory expectations and commercial priorities ...
Pharmaceutical marketing is undergoing a significant transformation as companies balance regulatory complexity, digital disruption, evolving workforce ex...
In biopharma, critical decisions are often shaped by more than clinical data, regulatory insights, or operational metrics. The most important signals m...
Artificial intelligence is transforming the role of advanced practice providers (APPs) by streamlining documentation, simplifying clinical workfl...
Targeted genetic medicines are reshaping the future of cancer treatment by improving the precision of therapeutic delivery while addressing the challenges ...
As artificial intelligence and advanced technologies transform the pharmaceutical industry, leaders face the challenge of harnessing innovation wit...
© 2026 Biopharma Boardroom. All Rights Reserved.
